Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Pearson

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Annals of the New York Academy of Sciences|November 20, 2002
Expression and functional characterization of the serine protease inhibitor neuroserpin in endocrine cellsRena M Hill, Leigh C Coates, Parmjeet K Parmar, et al.
Histopathology|March 3, 2015
Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patientsZac Gerring, John F Pearson, Helen R Morrin, et al.
Brain : a Journal of Neurology|March 11, 2021
The latitude gradient for multiple sclerosis prevalence is established in the early life courseClive E Sabel, John F Pearson, Deborah F Mason, et al.
Internal Medicine Journal|November 10, 2018
Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centreBarry D Hock, Katie S Mulholland, Peter Ganly, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2010
MS prevalence in New Zealand, an ethnically and latitudinally diverse countryBruce V Taylor, John F Pearson, Glynnis Clarke, et al.
Scientific Reports|March 31, 2021
Variable expression quantitative trait loci analysis of breast cancer risk variantsGeorge A R Wiggins, Michael A Black, Anita Dunbier, et al.
Plos One|September 15, 2023
Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumabBarry D Hock, Liping Goddard, Sean A MacPherson, et al.
Frontiers in Oncology|May 19, 2018
Investigation of Experimental Factors That Underlie <i>BRCA1/2</i> mRNA Isoform Expression Variation: Recommendations for Utilizing Targeted RNA Sequencing to Evaluate Potential Spliceogenic VariantsVanessa L Lattimore, John F Pearson, Margaret J Currie, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2014
Multiple sclerosis in New Zealand MāoriJohn F Pearson, Sridhar Alla, Glynnis Clarke, et al.
Epigenomics|September 6, 2018
Methylomic changes in response to micronutrient supplementation and MTHFR genotypeAaron J Stevens, Julia J Rucklidge, Kathryn A Darling, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Annals of the New York Academy of Sciences|November 20, 2002
Expression and functional characterization of the serine protease inhibitor neuroserpin in endocrine cellsRena M Hill, Leigh C Coates, Parmjeet K Parmar, et al.
Histopathology|March 3, 2015
Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patientsZac Gerring, John F Pearson, Helen R Morrin, et al.
Brain : a Journal of Neurology|March 11, 2021
The latitude gradient for multiple sclerosis prevalence is established in the early life courseClive E Sabel, John F Pearson, Deborah F Mason, et al.
Internal Medicine Journal|November 10, 2018
Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centreBarry D Hock, Katie S Mulholland, Peter Ganly, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2010
MS prevalence in New Zealand, an ethnically and latitudinally diverse countryBruce V Taylor, John F Pearson, Glynnis Clarke, et al.
Scientific Reports|March 31, 2021
Variable expression quantitative trait loci analysis of breast cancer risk variantsGeorge A R Wiggins, Michael A Black, Anita Dunbier, et al.
Plos One|September 15, 2023
Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumabBarry D Hock, Liping Goddard, Sean A MacPherson, et al.
Frontiers in Oncology|May 19, 2018
Investigation of Experimental Factors That Underlie <i>BRCA1/2</i> mRNA Isoform Expression Variation: Recommendations for Utilizing Targeted RNA Sequencing to Evaluate Potential Spliceogenic VariantsVanessa L Lattimore, John F Pearson, Margaret J Currie, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2014
Multiple sclerosis in New Zealand MāoriJohn F Pearson, Sridhar Alla, Glynnis Clarke, et al.
Epigenomics|September 6, 2018
Methylomic changes in response to micronutrient supplementation and MTHFR genotypeAaron J Stevens, Julia J Rucklidge, Kathryn A Darling, et al.
Pageof 10